FilingReader Intelligence
Kangtai Bio announces equity distribution and convertible bond adjustment
June 2, 2025 at 12:16 PM UTC•By FilingReader AI
Shenzhen Kangtai Biological Products (SZSE:300601) announced the implementation of its 2024 annual equity distribution plan, approved at the shareholders' meeting on May 20, 2025. Shareholders of record on June 5, 2025, will receive a cash dividend of CNY 0.90 (tax included) per 10 shares.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
News Alerts
Get instant email alerts when Shenzhen Kangtai Biological Products publishes news
Free account required • Unsubscribe anytime